Mesenchymal Stem Cell Therapy for Severe Sepsis and Septic Shock
Yıl: 2020 Cilt: 42 Sayı: 1 Sayfa Aralığı: 1 - 2 Metin Dili: İngilizce DOI: 10.14744/etd.2019.35336 İndeks Tarihi: 26-11-2020
Mesenchymal Stem Cell Therapy for Severe Sepsis and Septic Shock
Öz: -
Anahtar Kelime: Belge Türü: Makale Makale Türü: Editoryal Erişim Türü: Erişime Açık
- 1. Lyle NH, Pena OM, Boyd JH, Hancock RE. Barriers to the effective treatment of sepsis: antimicrobial agents, sepsis definitions, and hostdirected therapies. Ann N Y Acad Sci 2014;1323:101–14.
- 2. Keane C, Jerkic M, Laffey JG. Stem Cell-based Therapies for Sepsis. Anesthesiology 2017; 127(6): 1017–34.
- 3. Cohen J, Opal S, Calandra T. Sepsis studies need new direction. Lancet Infect Dis 2012; 12(7): 503–5.
- 4. Alhashem F, Tiren-Verbeet NL, Alp E, Doganay M. Treatment of sepsis: What is the antibiotic choice in bacteremia due to carbapenem resistant Enterobacteriaceae? World J Clin Cases 2017; 5(8): 324–32.
- 5. Lewis AJ, Seymour CW, Rosengart MR. Current Murine Models of Sepsis. Surg Infect (Larchmt) 2016; 17(4): 385–93.
- 6. Dinc G, Demiraslan H, Elmali F, Ahmed SS, Alp E, Doganay M. Antimicrobial efficacy of doripenem and its combinations with sulbactam, amikacin, colistin, tigecycline in experimental sepsis of carbapenem-resistant Acinetobacter baumannii. New Microbiol 2015; 38(1): 67–73.
- 7. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8(4): 315–7.
- 8. Gönen ZB, Demirci S, Doğan A, Sardoğan A, Ekizer A, Alkan A, et al. Characteristics of Mesenchymal Stem Cells Derived from the Apical Papilla of a Supernumerary Tooth Compared to Stem Cells Derived from the Dental Pulp. Erciyes Med J 2019; 41(1): 18–24.
- 9. Mei SH, Haitsma JJ, Dos Santos CC, Deng Y, Lai PF, Slutsky AS, et al. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am J Respir Crit Care Med 2010; 182(8): 1047–57.
- 10. N émeth K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 2009; 15(1): 42–9.
- 11. Krasnodembskaya A, Song Y, Fang X, Gupta N, Serikov V, Lee JW, et al. Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Stem Cells 2010; 28(12): 2229–38.
- 12. Hackstein H, Lippitsch A, Krug P, Schevtschenko I, Kranz S, Hecker M, et al. Prospectively defined murine mesenchymal stem cells inhibit Klebsiella pneumoniae-induced acute lung injury and improve pneumonia survival. Respir Res 2015; 16: 123.
- 13. Hong J, Hueckelhoven A, Wang L, Schmitt A, Wuchter P, Tabarkiewicz J, et al. Indoleamine 2,3-dioxygenase mediates inhibition of virus-specific CD8(+) T cell proliferation by human mesenchymal stromal cells. Cytotherapy 2016; 18(5): 621–9.
- 14. Pittenger MF, Discher DE, P éault BM, Phinney DG, Hare JM, Caplan AI. Mesenchymal stem cell perspective: cell biology to clinical progress. NPJ Regen Med 2019; 4: 22.
- 15. Hayes M, Masterson C, Devaney J, Barry F, Elliman S, O’Brien T, et al. Therapeutic efficacy of human mesenchymal stromal cells in the repair of established ventilator-induced lung injury in the rat. Anesthesiology 2015; 122(2): 363–73.
| APA | GÖNEN BURÇİN Z, DİNÇ G, Doganay M (2020). Mesenchymal Stem Cell Therapy for Severe Sepsis and Septic Shock. , 1 - 2. 10.14744/etd.2019.35336 |
| Chicago | GÖNEN BURÇİN Zeynep,DİNÇ Gökçen,Doganay Mehmet Mesenchymal Stem Cell Therapy for Severe Sepsis and Septic Shock. (2020): 1 - 2. 10.14744/etd.2019.35336 |
| MLA | GÖNEN BURÇİN Zeynep,DİNÇ Gökçen,Doganay Mehmet Mesenchymal Stem Cell Therapy for Severe Sepsis and Septic Shock. , 2020, ss.1 - 2. 10.14744/etd.2019.35336 |
| AMA | GÖNEN BURÇİN Z,DİNÇ G,Doganay M Mesenchymal Stem Cell Therapy for Severe Sepsis and Septic Shock. . 2020; 1 - 2. 10.14744/etd.2019.35336 |
| Vancouver | GÖNEN BURÇİN Z,DİNÇ G,Doganay M Mesenchymal Stem Cell Therapy for Severe Sepsis and Septic Shock. . 2020; 1 - 2. 10.14744/etd.2019.35336 |
| IEEE | GÖNEN BURÇİN Z,DİNÇ G,Doganay M "Mesenchymal Stem Cell Therapy for Severe Sepsis and Septic Shock." , ss.1 - 2, 2020. 10.14744/etd.2019.35336 |
| ISNAD | GÖNEN BURÇİN, Zeynep vd. "Mesenchymal Stem Cell Therapy for Severe Sepsis and Septic Shock". (2020), 1-2. https://doi.org/10.14744/etd.2019.35336 |
| APA | GÖNEN BURÇİN Z, DİNÇ G, Doganay M (2020). Mesenchymal Stem Cell Therapy for Severe Sepsis and Septic Shock. Erciyes Medical Journal, 42(1), 1 - 2. 10.14744/etd.2019.35336 |
| Chicago | GÖNEN BURÇİN Zeynep,DİNÇ Gökçen,Doganay Mehmet Mesenchymal Stem Cell Therapy for Severe Sepsis and Septic Shock. Erciyes Medical Journal 42, no.1 (2020): 1 - 2. 10.14744/etd.2019.35336 |
| MLA | GÖNEN BURÇİN Zeynep,DİNÇ Gökçen,Doganay Mehmet Mesenchymal Stem Cell Therapy for Severe Sepsis and Septic Shock. Erciyes Medical Journal, vol.42, no.1, 2020, ss.1 - 2. 10.14744/etd.2019.35336 |
| AMA | GÖNEN BURÇİN Z,DİNÇ G,Doganay M Mesenchymal Stem Cell Therapy for Severe Sepsis and Septic Shock. Erciyes Medical Journal. 2020; 42(1): 1 - 2. 10.14744/etd.2019.35336 |
| Vancouver | GÖNEN BURÇİN Z,DİNÇ G,Doganay M Mesenchymal Stem Cell Therapy for Severe Sepsis and Septic Shock. Erciyes Medical Journal. 2020; 42(1): 1 - 2. 10.14744/etd.2019.35336 |
| IEEE | GÖNEN BURÇİN Z,DİNÇ G,Doganay M "Mesenchymal Stem Cell Therapy for Severe Sepsis and Septic Shock." Erciyes Medical Journal, 42, ss.1 - 2, 2020. 10.14744/etd.2019.35336 |
| ISNAD | GÖNEN BURÇİN, Zeynep vd. "Mesenchymal Stem Cell Therapy for Severe Sepsis and Septic Shock". Erciyes Medical Journal 42/1 (2020), 1-2. https://doi.org/10.14744/etd.2019.35336 |
